Site Search
Professionals 647 results
Capabilities 87 results
Practice Area
Product Liability & Mass Torts
Major multinational companies trust Winston to defend their products and reputations in high-profile, high-stakes product liability and mass tort claims. Our Product Liability & Mass Torts Practice is one of the industry’s most seasoned, with a deep bench of experienced lawyers and a unique combination of extensive trial experience and expansive technical knowledge.
Industry
Energy Industry Litigation & Investigations
With our reputation as a trial lawyers’ firm serving as our foundation, we advocate for a variety of power producers, oil and gas companies, and oilfield services providers in high-stakes litigation throughout U.S. district and appellate courts. We also handle sensitive investigations, contentious regulatory and enforcement issues, and arbitration. Our bench is stacked with innovative legal and commercial problem solvers, many of whom came to Winston from in-house positions, amplifying their appreciation for C-suite complexities. By combining our knowledge of the energy industry with first-rate trial skills, and the experience our practitioners have gained from learning our clients’ businesses, we are positioned to obtain the best result for our clients efficiently—whether in the courtroom or a negotiated solution.
Practice Area
Brands across key sectors turn to Winston litigators to defend their reputations in advertising class actions, competitor disputes, and investigations. With litigators based in the U.S.’s busiest jurisdictions—including courts in California, Florida, Illinois, New York, and Texas—we have deep experience and prowess in handling some of the most high-profile and business-essential advertising cases in recent history. These disputes have involved false advertising; unfair competition, unfair business practices, and unjust enrichment; copyright, trade name, and service mark infringement; consumer-protection claims; and violations of the Lanham Act.
Experience 163 results
Experience
|August 19, 2025
Winston advised Ellipsis U.S. Onshore Holdings LLC, a portfolio company of the Westlawn Group, in connection with the acquisition of high-quality, non-operated working interests in the Permian Basin of Texas and New Mexico—adding approximately 4,000 barrels of oil equivalent per day in net production and over 600 gross remaining drilling locations. This strategic transaction strengthens Ellipsis’ Delaware Basin footprint and supports its strategy of scaling through high-margin, low-cost assets.
Experience
|May 27, 2025
PicoCELA Inc. Closes $1.8 Public Offering
Winston & Strawn represented Revere Securities LLC acted as the lead placement agent in connection with PicoCELA, Inc. in the closing of its public offering of 6,100,000 American Depositary Shares ("ADSs") at a public placement price of $0.30 per ADS. PicoCELA, Inc. received an aggregate gross proceeds of $1.83 million before deducting placement agent commission and other offering expenses. Each ADS represents one common share of the Company.
Experience
|May 9, 2025
An Am Law LOTW Shout Out-Worthy Gold Medal Victory In $Jenner
Winston, led by partners Jeffrey Steinfeld, John Schreiber, and George Mastoris, secured full dismissal of a high-profile securities class action involving hundred of millions of dollars in $Jenner memecoin trades. Plaintiffs alleged securities fraud under federal and California laws. The team was recognized in Am Law’s Litigator of the Week column for the win.
Insights & News 4,883 results
Seminar/CLE
|September 18, 2025
Winston Hosts New York Financial Services Symposium
Winston’s Financial Services Industry Group is pleased to host our inaugural Financial Services Symposium in our New York office on Thursday, September 18, 2025. This event will include a half-day of programming led by top industry thought leaders. Below you will find details about each panel.
Product Liability & Mass Torts Digest
|September 17, 2025
|4 Min Read
Supreme Court To Settle if All’s Well That Ends Well in Diversity Jurisdiction
The Supreme Court has granted certiorari in Hain Celestial Group, Inc. v. Palmquist to determine whether a final order issued by a federal court may stand if an appellate court later determines the district court erred in dismissing a nondiverse defendant and denying a motion to remand.
Recognitions
|September 17, 2025
|1 Min Read
Winston Partners Named to Forbes’ 2025 America’s Top Lawyers List
Winston & Strawn partners have been recognized on Forbes’ 2025 America’s Top Lawyers list. This accolade highlights lawyers who have distinguished themselves through notable deals and transactions, impressive trial work, wise counsel, and respect from colleagues and clients.
Other Results 144 results
Law Glossary
What Are Interchangeable Biological Products?
A biological product is interchangeable if it is biosimilar to the reference product and is expected to produce the same clinical result as the reference product in any given patient. A biosimilar product that is deemed to be interchangeable by the FDA means the biosimilar product can be substituted for the reference product by a pharmacist without consulting the prescriber. The specific requirements for substitution vary by state.
Law Glossary
What Is Advertising Litigation?
Advertising litigation is defined as the legal area that covers false or deceptive advertising cases. Lawsuits may be brought by government agencies or corporate competitors based on the Lanham Act—a law that specifically deals with false advertising. The Act outlines how an advertisement can be deemed false. The Federal Trade Commission (FTC) has the ability to file lawsuits to halt deceptive advertising claims. The U.S. Food and Drug Administration may also pursue advertising litigation against violators of government regulations. Companies may be called on to substantiate their advertising claims, whether these are made in print or online.
Site Content
In the product liability context, general causation is the legal and scientific determination of whether the product in question has the inherent capability to cause the alleged injury under certain circumstances. Establishment of general causation is a critical aspect of a plaintiff’s case, and typically requires scientific evidence, such as epidemiology or toxicology, and expert testimony to establish a causal connection between the product’s design, manufacturing, or warnings and the injury or injuries at issue. As contrasted to specific causation, the focus in a general causation inquiry is on whether the product or exposure, as a general matter, can cause the type of injury claimed by the plaintiff. A general causation inquiry does not assess any facts unique to a particular plaintiff.